European Medicines Agency Grants Bexobrutideg (NX-5948) Orphan Drug Designation for the Treatment of Lymphoplasmacytic Lymphoma, also Known as Waldenstrom Macroglobulinemia Regulatory momentum builds for bexobrutideg with multiple designations across the United States and EU, Including EMA PRIME and FDA Fast Track for CLL/SLL GlobeNewswire July 07, 2025 SAN FRANCISCO, July 07, 2025 (GLOBE NEWSWIRE) — […]

Aya Gold & Silver Reports High-Grade Boumadine Exploration Results, Expands Imariren to 1km and Identifies New High-Grade Asirem Zone to the West GlobeNewswire July 07, 2025 MONTREAL, July 07, 2025 (GLOBE NEWSWIRE) — Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) is pleased to announce new high-grade drill exploration results

Inventus Reports 4.10 gpt Gold and 1.78 Metre Average in 30 Drill Holes Within 6 Metres of Surface at the 10,000-Tonne Trench 1 Bulk Sample Site GlobeNewswire July 07, 2025 TORONTO, July 07, 2025 (GLOBE NEWSWIRE) — Inventus Mining Corp. (TSXV: IVS) (“Inventus” or the “Company”) is pleased to announce final assays from grade-control drilling

Unicycive Therapeutics to Present at the H.C. Wainwright 4th Annual Kidney Virtual Conference GlobeNewswire July 07, 2025 LOS ALTOS, Calif., July 07, 2025 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced that Shalabh Gupta, M.D., Chief Executive Officer,

Shoals Technologies Group, Inc. Announces Second Quarter 2025 Earnings Release Date and Conference Call GlobeNewswire July 07, 2025 PORTLAND, Tenn., July 07, 2025 (GLOBE NEWSWIRE) — Shoals Technologies Group, Inc. (the “Company”) (Nasdaq: SHLS) today announced that the Company will release its second quarter 2025 results before market open on Tuesday, August 5, 2025, to

OTC Markets Group Welcomes Vroom, Inc. to OTCQX GlobeNewswire July 07, 2025 NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Vroom, Inc. (“Vroom”) (OTCQX: VRMWW), a leading automotive finance company and a data and AI-powered analytics

Flagship Communities Real Estate Investment Trust to Host Conference Call for Second Quarter 2025 Results GlobeNewswire July 07, 2025 Not for distribution to U.S. newswire services or dissemination in the United States. TORONTO, July 07, 2025 (GLOBE NEWSWIRE) — Flagship Communities Real Estate Investment Trust (TSX: MHC.U) (TSX:MHC.UN) (“Flagship” or the “REIT”) today announced that

Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism GlobeNewswire July 07, 2025 WARREN, N.J., July 07, 2025 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ:AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, announced today that the Aquestive

OMass Therapeutics to Present New Preclinical Data For its Best-in-Class MC2 Program at ENDO 2025 GlobeNewswire July 07, 2025 Oxford, United Kingdom – 7th July 2025 – OMass Therapeutics ('OMass' or 'the Company'), a biotechnology company identifying medicines against highly validated target ecosystems such as membrane proteins or intracellular complexes, today announces that preclinical data

Carlton Announces Results of Annual and Special Meeting of Shareholders GlobeNewswire July 07, 2025 TORONTO, July 07, 2025 (GLOBE NEWSWIRE) — Carlton Precious Inc. (TSX-V: CPI | OTCQB: NBRFF) (“Carlton” or the “Company“) is pleased to announce the results of its annual and special meeting of shareholders (the “Meeting”) held July 3, 2025. A total